General

Home>News>General

‘Off-the-Shelf’ Immunotherapy: Manufacture of Cancer-Killing Cells from Donor Cells

‘Off-the-Shelf’ Immunotherapy: Manufacture of CD8+ T Cells Derived from Hematopoietic Stem Cells

Cellular immunotherapy is revolutionizing cancer treatment. However, treatments created from each patient’s cells are complex, costly, and limited by the number and quality of killer T cells that can be isolated from and expanded for re-infusion into each patient.

In this […]

2021-10-08T13:43:35+11:00October 8th, 2021|

Cartherics CEO contributes his expertise

Alan Trounson joins regenerative medicine advisory committee

By Leigh Dayton

7 October 2021

According to Cartherics CEO Alan Trounson, taking ideas from the laboratory to the marketplace is a “long and tortuous process”. First-hand experience goes far towards identifying and navigating the hurdles of research translation.

And experience – from pioneering work in IVF and embryonic stem cell science […]

2021-10-07T09:43:41+11:00October 7th, 2021|

Cartherics Board Member hits the Airwaves

On Thursday, 2 September, in an interview with Jack Hodgins on 2NUR.FM’s ‘Wellbeing’ segment, Professor Bryan Williams (Cartherics Non-Executive Board Member) spoke about COVID-19, viruses and how vaccines control them, and the importance of medical research.

“I would encourage Australians to convince their politicians that they need to increase the research budget in Australia, […]

2021-09-14T12:41:24+10:00September 14th, 2021|

WEHI Doctoral Student Wins Cartherics Award

Natalia Benetti’s winning presentation was a hit at virtual Victorian meeting

https://www.anzscdb.org/

By Leigh Dayton

27 August 2021

Cartherics CEO Alan Trounson congratulates Natalia Benetti for her important research in developmental cell biology: “It’s great work and very well presented”.

The company also applauds the Australian Regenerative Medicine Institute for successfully organising the 13th Victorian State Conference of the […]

2021-08-27T19:08:02+10:00August 27th, 2021|

Cartherics CEO Alan Trounson gets pat on the back from the National Library of Australia

By Leigh Dayton

9 August 2021

Cartherics is pleased to announce that CEO Alan Trounson has been congratulated by the National Library of Australia for his recognition on this year’s Queen’s Birthday Honours List.

In recognition of his “distinguished service to medical science, and to in vitro fertilisation and stem cell technologies” Trounson was appointed an […]

2021-08-09T14:03:10+10:00August 9th, 2021|

Victorian development biologists are gathering in August & Cartherics joins the intellectual party

By Leigh Dayton

22 July 2021

Cartherics is delighted to announce that it is a sponsor of the Australia and New Zealand Society of Cell and Developmental Biology’s Victorian State Conference. The highly regarded one-day event is booked for 26 August at the University of Melbourne.

Cartherics CEO Alan Trounson welcomes the opportunity to support the meeting.

“It is […]

2021-07-22T12:58:44+10:00July 22nd, 2021|

Cartherics, ARMI and CCRM Australia announce new agreement for closer cooperation and collaboration

Cartherics Pty Ltd and the Australian Regenerative Medicine Institute (ARMI), including commercialisation initiative CCRM Australia, announced agreements for closer cooperation and collaboration today.

“Cartherics affiliation with ARMI is an important step in our development and will embed industry and academic excellence in regenerative medicine and translation to clinical medicine in cancer,” said Prof Alan Trounson, Cartherics […]

2021-07-05T09:56:45+10:00July 5th, 2021|

Super-Charging the Immune System to Fight Cancer

Innovative immunotherapies for cancer are a step closer to reality thanks to a commercial licence agreement between Australia’s Cartherics Pty. Ltd. and South Korea-based ToolGen, Inc.

Melbourne, Australia and Seoul, South Korea

28 June 2021

Cartherics Pty Ltd (“Cartherics”) and ToolGen, Inc. (“ToolGen”) announced today that they have entered into a commercial licence agreement.

Under the agreement, Cartherics obtains […]

2021-06-28T10:00:38+10:00June 28th, 2021|

Cancer survivor Heather Hawkins was devastated by news that early detection of ovarian cancer doesn’t save lives …..

But she has “unshakeable hope” that Cartherics’ innovative treatments promise an alternative path

By Heather Hawkins

24 May 2021

Ovarian Cancer: two words that changed my life forever.

Even today – and it’s been 14 years since diagnosis – they still evoke a very raw and deeply emotional response. It was the first time I’d faced the undeniable fact […]

2021-05-24T14:13:27+10:00May 24th, 2021|

Cartherics Therapies More Essential Than Ever

New research delivers devastating findings about ovarian cancer screening

Four Australian women are diagnosed with ovarian cancer a day and three will eventually die from the disease. It’s usually diagnosed late, because few women show symptoms until they have advanced cancer.

As a junior doctor in London in the mid-1980s, Ian Jacobs saw women undergo chemo and […]

2021-05-20T14:20:54+10:00May 20th, 2021|
Go to Top